UCL startup acquired by biotechnology company in bid to find cancer drugs in 'record time' | Science
Photo: UCL website. Machine learning company, Rahko, has been bought by US-based biotechnology firm, Odyssey Therapeutics, in a move that will bring together artificial intelligence and drug-discovery software to improve medical development for patients with cancer and inflammatory diseases.